131 related articles for article (PubMed ID: 1869297)
41. Conditioned gustatory avoidance induced by three cholinergic agents.
Preston KL; Schuster CR
Pharmacol Biochem Behav; 1981 Nov; 15(5):827-8. PubMed ID: 7312919
[TBL] [Abstract][Full Text] [Related]
42. Assessment of the muscarinic receptor subtype involved in the mediation of pilocarpine-induced purposeless chewing behaviour.
Stewart BR; Jenner P; Marsden CD
Psychopharmacology (Berl); 1989; 97(2):228-34. PubMed ID: 2498932
[TBL] [Abstract][Full Text] [Related]
43. [Effect of microinjections of a selective blocker of M1-muscarinic receptors pirenzepine into the neostriatum on the rat motor activity].
Shapovalova KB; Kamkina IuV; Mysovskiĭ DA
Ross Fiziol Zh Im I M Sechenova; 2004 Feb; 90(2):129-36. PubMed ID: 15143500
[TBL] [Abstract][Full Text] [Related]
44. Differential effects of M1 and M2 muscarinic drugs on septohippocampal, hippocampal and cortical neurons in the rat.
Rascol O; Lamour Y
Brain Res; 1988 Apr; 446(2):303-13. PubMed ID: 3370492
[TBL] [Abstract][Full Text] [Related]
45. Synthesis of (1-azabicyclo[3.3.0]octanyl)methyl-substituted aromatic heterocycles and their muscarinic activity.
Suzuki T; Uesaka H; Hamajima H; Ikami T
Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):876-9. PubMed ID: 10399839
[TBL] [Abstract][Full Text] [Related]
46. Biochemical and behavioral characterization of a novel cholinergic agonist, SR 95639.
Boast CA; Leventer S; Sabb A; Abelson M; Bender R; Giacomo D; Maurer S; McArthur S; Mehta O; Morris H
Pharmacol Biochem Behav; 1991 Jun; 39(2):287-92. PubMed ID: 1658814
[TBL] [Abstract][Full Text] [Related]
47. Double dissociation between the effects of muscarinic antagonists and benzodiazepine receptor agonists on the acquisition and retention of passive avoidance.
Cole BJ; Jones GH
Psychopharmacology (Berl); 1995 Mar; 118(1):37-41. PubMed ID: 7597120
[TBL] [Abstract][Full Text] [Related]
48. Pharmacological studies on novel muscarinic agonists, 1-oxa-8-azaspiro[4.5]decane derivatives, YM796 and YM954.
Wanibuchi F; Konishi T; Harada M; Terai M; Hidaka K; Tamura T; Tsukamoto S; Usuda S
Eur J Pharmacol; 1990 Oct; 187(3):479-86. PubMed ID: 1963596
[TBL] [Abstract][Full Text] [Related]
49. Systemic injection of pirenzepine induces a deficit in passive avoidance learning in rats.
Worms P; Gueudet C; Pério A; Soubrié P
Psychopharmacology (Berl); 1989; 98(2):286-8. PubMed ID: 2502800
[TBL] [Abstract][Full Text] [Related]
50. Central cholinergic agents. III. Synthesis of 2-alkoxy-2,8- diazaspiro[4.5]decane-1,3-diones as muscarinic agonists.
Ishihara Y; Yukimasa H; Miyamoto M; Goto G
Chem Pharm Bull (Tokyo); 1992 May; 40(5):1177-85. PubMed ID: 1394631
[TBL] [Abstract][Full Text] [Related]
51. Effects of muscarinic receptor agonists and anticholinesterase drugs on high voltage spindles and slow waves.
Riekkinen P; Riekkinen M; Fisher A; Ekonsalo T; Sirviö J
Eur J Pharmacol; 1993 Aug; 240(1):1-7. PubMed ID: 8405117
[TBL] [Abstract][Full Text] [Related]
52. Disturbance of learning and memory by the alkylation of muscarinic acetylcholine receptors by propylbenzilylcholine mustard.
Uchida S; Fukuchi I; Kato S; Nakahiro M; Yoshida H
Gerontology; 1991; 37 Suppl 1():12-6. PubMed ID: 1937064
[TBL] [Abstract][Full Text] [Related]
53. Effects of the selective M1 muscarinic receptor antagonist dicyclomine on emotional memory.
Fornari RV; Moreira KM; Oliveira MG
Learn Mem; 2000; 7(5):287-92. PubMed ID: 11040260
[TBL] [Abstract][Full Text] [Related]
54. Reversal of haemorrhagic shock in rats by cholinomimetic drugs.
Guarini S; Tagliavini S; Ferrari W; Bertolini A
Br J Pharmacol; 1989 Sep; 98(1):218-24. PubMed ID: 2804546
[TBL] [Abstract][Full Text] [Related]
55. Effect of some cholinergic drugs on the conditioned pole jump response in rats.
Bhargava VK; Pushpavati CP
Pharmacol Biochem Behav; 1981 Oct; 15(4):537-8. PubMed ID: 7291256
[TBL] [Abstract][Full Text] [Related]
56. Post-training injection of the acetylcholine M2 receptor antagonist AF-DX 116 improves memory.
Packard MG; Regenold W; Quirion R; White NM
Brain Res; 1990 Jul; 524(1):72-6. PubMed ID: 2400933
[TBL] [Abstract][Full Text] [Related]
57. Central administration of the muscarinic receptor subtype-selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouse.
Caulfield MP; Higgins GA; Straughan DW
J Pharm Pharmacol; 1983 Feb; 35(2):131-2. PubMed ID: 6131987
[No Abstract] [Full Text] [Related]
58. Nonassociative explanations of behavioral changes induced by central cholinergic drugs.
Bignami G
Acta Neurobiol Exp (Wars); 1976; 36(1-2):5-90. PubMed ID: 788471
[TBL] [Abstract][Full Text] [Related]
59. Drug effects on avoidance behavior in selected strains of rats.
Brimblecombe RW; Buxton DA; Redfern PH
Br J Pharmacol; 1975 Mar; 53(3):461P. PubMed ID: 1137758
[No Abstract] [Full Text] [Related]
60. Cholinomimetic activities of minaprine.
Worms P; Kan JP; Steinberg R; Terranova JP; Perio A; Biziere K
Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):411-8. PubMed ID: 2586634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
